Cited by 1,220DNA Repair MechanismsEffects of Radiation ExposureProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM

Open access

Hickson, Ian, Zhao, Yan, Richardson, Caroline J., Green, Sharon J., Martin, Niall M. B., Orr, Alisdair I., Reaper, Philip M., Jackson, Stephen P., Curtin, Nicola J., Smith, Graeme C. M.·2004·Cancer Research

DOI 10.1158/0008-5472.can-04-2727

Open this paper in CoChat — free account

Abstract

The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1. Mutation of ATM occurs in the human autosomal recessive disorder ataxia-telangiectasia, which is characterized by hypersensitivity to ionizing radiation and a failure of cells to arrest the cell cycle after the induction of DNA double-strand breaks. It has thus been proposed that ATM inhibition would cause cellular radio- and chemosensitization. Through screening a small molecule compound library developed for the phosphatidylinositol 3'-kinase-like kinase family, we identified an ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933), that inhibits ATM with an IC(50) of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-2727

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,050

Show all 58 references

Research works printed but not linked: 1

Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK

Sorted by citations

Items 301–400 of 1,000

Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination
Lescale, C., Hasse, H. L., Blackford, A. N., Balmus, G., Bianchi, J. J., Yu, W., Bacoccina, L., Jarade, A., Clouin, C., Sivapalan, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.069 · Cited by 86
Self-citation
Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase
Hollick, J. J., Rigoreau, L. J. M., Cano, C., Cockcroft, X. F., Curtin, N. J., Frigerio, M., Golding, B. T., Guiard, S., Hardcastle, I. R., Hickson, I., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061121y · Cited by 85
Self-citation
Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response
Solier, S., Kohn, K. W., Scroggins, B. T., Xu, W., Trepel, J. B., Neckers, L. Μ., & Pommier, Y. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203617109 · Cited by 87
The DNA translocase activity of FANCM protects stalled replication forks
Blackford, A. N., Schwab, R. A., Nieminuszczy, J., Deans, A. J., West, S. C., & Niedźwiedź, W. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds013 · Cited by 89
Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies
Kim, S., Nair, D. M., Romero, M. M., Serna, V. A., Koleske, A. J., Woodruff, T. K., & Kurita, T. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0151-2 · Cited by 84
Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis
Harbort, C. J., Pereira, P. V. S., von Bernuth, H., Kaindl, A. M., Costa‐Carvalho, B. T., Condino‐Neto, A., Reichenbach, J., Roesler, J., Zychlinsky, A., & Amulic, B. (2015) · Blood · doi:10.1182/blood-2015-05-645424 · Cited by 82
High Basal γH2AX Levels Sustain Self-Renewal of Mouse Embryonic and Induced Pluripotent Stem Cells
Turinetto, V., Orlando, L., Sanchez-Ripoll, Y., Kumpfmueller, B., Storm, M. P., Porcedda, P., Minieri, V., Saviozzi, S., Accomasso, L., Rocchietti, E. C., et al. (2012) · Stem Cells · doi:10.1002/stem.1133 · Cited by 85
Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional
Lossaint, G., Besnard, E., Fisher, D., Piette, J., & Dulić, V (2011) · Oncogene · doi:10.1038/onc.2011.135 · Cited by 83
Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration
Yang, D., Halaby, M., Li, Y., Hibma, J. C., & Burn, P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.001 · Cited by 83
The Cellular Ataxia Telangiectasia-Mutated Kinase Promotes Epstein-Barr Virus Lytic Reactivation in Response to Multiple Different Types of Lytic Reactivation-Inducing Stimuli
Hagemeier, S. R., Barlow, E. A., Meng, Q., & Kenney, S. C. (2012) · Journal of Virology · doi:10.1128/jvi.01850-12 · Cited by 86
Homeostatic nuclear RAGE–ATM interaction is essential for efficient DNA repair
Kumar, V., Fleming, T. H., Terjung, S., Gorzelanny, C., Gebhardt, C., Agrawal, R., Mall, M. A., Ranzinger, J., Zeier, M. G., Madhusudhan, T., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx705 · Cited by 82
ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells
Marabitti, V., Lillo, G., Malacaria, E., Palermo, V., Sanchez, M., Pichierri, P., & Franchitto, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz025 · Cited by 82
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
Koll, T. T., Feis, S. S., Wright, M. H., Teniola, M. M., Richardson, M. M., Robles, A. I., Bradsher, J., Capala, J., & Varticovski, L. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2104 · Cited by 82
High osmolality activates the G1 and G2 cell cycle checkpoints and affects the DNA integrity of nucleus pulposus intervertebral disc cells triggering an enhanced DNA repair response
Mavrogonatou, E., & Kletsas, D. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.05.005 · Cited by 82
Lack of DNA Polymerase θ (POLQ) Radiosensitizes Bone Marrow Stromal CellsIn Vitroand Increases Reticulocyte Micronuclei after Total-Body Irradiation
Goff, J. P., Shields, D. S., Seki, M., Choi, S., Epperly, M. W., Dixon, T. M., Wang, H., Bakkenist, C. J., Dertinger, S. D., Torous, D. K., et al. (2009) · Radiation Research · doi:10.1667/rr1598.1 · Cited by 82
ATR-dependent pathways control hEXO1 stability in response to stalled forks
El‐Shemerly, M., Heß, D., Pyakurel, A., Moselhy, S. S., & Ferrari, S. M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1052 · Cited by 82
DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair
Tomimatsu, N., Mukherjee, B., Harris, J. L., Boffo, F. L., Hardebeck, M. C., Potts, P. R., Khanna, K. K., & Burma, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772475 · Cited by 85
Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis
Difilippantonio, S., Celeste, A., Kruhlak, M. J., Lee, Y., Difilippantonio, M. J., Feigenbaum, L., Jackson, S. P., McKinnon, P. J., & Nussenzweig, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070319 · Cited by 87
Self-citation
The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase
Malagu, K., Duggan, H. M. E., Menear, K. A., Hummersone, M., Gomez, S., Bailey, C., Edwards, P., Drzewiecki, J., Leroux, F. R., Quesada, M. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.038 · Cited by 81
Self-citation
ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks
Khalil, A. A., Morgan, R. N., Adams, B. R., Golding, S. E., Dever, S. M., Rosenberg, E., Povirk, L. F., & Valerie, K. C. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14713 · Cited by 80
Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM
McCabe, N., Hanna, C., Walker, S. M., Gonda, D. D., Li, J., Wikström, K., Savage, K. I., Butterworth, K. T., Chen, C. C., Harkin, D. P., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3502 · Cited by 81
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Degorce, S. L., Barlaam, B. C., Cadogan, E. B., Dishington, A. P., Ducray, R., Glossop, S. C., Hassall, L. A., Lach, F., Lau, A., McGuire, T. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00519 · Cited by 80
Regulation of SIRT1 activity by genotoxic stress
Yuan, J., Luo, K., Liu, T., & Lou, Z. (2012) · Genes & Development · doi:10.1101/gad.188482.112 · Cited by 79
Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis
Demoulin, B., Hermant, M., Castrogiovanni, C., Staudt, C., & Dumont, P. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.04.015 · Cited by 81
Multiple Mechanisms Downstream of TLR-4 Stimulation Allow Expression of NKG2D Ligands To Facilitate Macrophage/NK Cell Crosstalk
Eissmann, P., Evans, J. H., Mehrabi, M., Rose, E. L., Nedvetzki, S., & Davis, D. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903985 · Cited by 83
Phasor histone FLIM-FRET microscopy quantifies spatiotemporal rearrangement of chromatin architecture during the DNA damage response
Lou, J., Scipioni, L., Wright, B. K., Bartolec, T. K., Zhang, J., Masamsetti, V. P., Gaus, K., Gratton, E., Cesare, A. J., & Hinde, E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814965116 · Cited by 77
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer
Hu, Y., & Guo, M. (2020) · Cancer Science · doi:10.1111/cas.14565 · Cited by 82
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy
Albarakati, N., Abdel-Fatah, T. M. A., Doherty, R. E., Russell, R., Agarwal, D., Moseley, P. M., Perry, C., Arora, A., Alsubhi, N. H., Seedhouse, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.001 · Cited by 79
Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR
Jowsey, P. A., Morrice, N. A., Hastie, C. J., McLauchlan, H., Toth, R. L., & Rouse, J. W. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.04.011 · Cited by 82
Defective homologous recombination in human cancers
Cerbinskaite, A., Mukhopadhyay, A., Plummer, E. R., Curtin, N. J., & Edmondson, R. J. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.015 · Cited by 79
Self-citation
Distinct genetic control of homologous recombination repair of Cas9-induced double-strand breaks, nicks and paired nicks
Vriend, L. E. M., Prakash, R., Chen, C.-C., Vanoli, F., Cavallo, F., Zhang, Y., Jasin, M., & Krawczyk, P. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw179 · Cited by 77
A Surveillance Mechanism Ensures Repair of DNA Lesions during Zygotic Reprogramming
Ladstätter, S., & Tachibana-Konwalski, K. (2016) · Cell · doi:10.1016/j.cell.2016.11.009 · Cited by 77
Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria
Qian, M., Liu, Z., Peng, L., Tang, X., Meng, F., Ao, Y., Zhou, M., Wang, M., Cao, X., Qin, B., et al. (2018) · eLife · doi:10.7554/elife.34836 · Cited by 77
Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
Ferri, A., Stagni, V., & Barilà, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144910 · Cited by 83
The Chromatin Response to Double-Strand DNA Breaks and Their Repair
Aleksandrov, R., Hristova, R. H., Stoynov, S., & Gospodinov, A. G. (2020) · Cells · doi:10.3390/cells9081853 · Cited by 79
Impaired DNA damage response — An Achilles' heel sensitizing cancer to chemotherapy and radiotherapy
Darżynkiewicz, Z., Traganos, F., & Włodkowic, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.032 · Cited by 76
Ataxia Telangiectasia Mutated and p21CIP1 Modulate Cell Survival of Drug-Induced Senescent Tumor Cells: Implications for Chemotherapy
Crescenzi, E., Palumbo, G. A., de Boer, J., & Brady, H. J. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4298 · Cited by 79
RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health
Feeney, L., Munoz, I. M., Lachaud, C., Toth, R. L., Appleton, P. L., Schindler, D., & Rouse, J. W. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.021 · Cited by 77
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Forrest, R. A., Swift, L. P., Rephaeli, A., Nudelman, A., Kimura, K., Phillips, D. R., & Cutts, S. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.026 · Cited by 82
Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death
Scheffel, M. J., Scurti, G. M., Simms, P. E., Garrett-Mayer, E. S., Mehrotra, S., Nishimura, M. I., & Voelkel‐Johnson, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0587 · Cited by 75
Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics
Bhattacharjee, S., & Nandi, S. (2017) · IUBMB Life · doi:10.1002/iub.1696 · Cited by 76
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response
Huang, C., Hsieh, F., Wang, C., Chen, L., Chang, S.-S., Tsai, M.-H., Hung, M., Kuo, C.-W., Shih, C.-T., Chao, T., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.010 · Cited by 74
Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
Curtin, N. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12244 · Cited by 78
Self-citation
The DNA Damage Response Induced by Infection with Human Cytomegalovirus and Other Viruses
Xiaofei, E., & Kowalik, T. F. (2014) · Viruses · doi:10.3390/v6052155 · Cited by 80
Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex
Guirouilh‐Barbat, J., Redon, C. E., & Pommier, Y. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0215 · Cited by 78
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
Armstrong, S. A., Schultz, C. W., Azimi-Sadjadi, A., Brody, J. R., & Pishvaian, M. J. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0208 · Cited by 78
ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia
Grosjean-Raillard, J., Tailler, M., Adès, L., Perfettini, J., Fabre, C., Braun, T., de Botton, S., Fenaux, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.457 · Cited by 74
Nuclear Ataxia-Telangiectasia Mutated (ATM) Mediates the Cellular Response to DNA Double Strand Breaks in Human Neuron-like Cells
Biton, S., Dar, I., Mittelman, L. A., Pereg, Y., Barzilai, A., & Shiloh, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601895200 · Cited by 73
Mechanism of heat stress-induced cellular senescence elucidates the exclusive vulnerability of early S-phase cells to mild genotoxic stress
Velichko, A. K., Petrova, N. V., Razin, S. V., & Kantidze, O. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv573 · Cited by 74
Nonhomologous End Joining Is Essential for Cellular Resistance to the Novel Antitumor Agent, β-Lapachone
Srougi, M. C., Reinicke, K. E., Dong, Y., Bey, E. A., & Boothman, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0935 · Cited by 73
CtIP-dependent DNA resection is required for DNA damage checkpoint maintenance but not initiation
Kousholt, A. N., Fugger, K., Hoffmann, S., Larsen, B. D., Menzel, T., Sartori, A. A., & Sørensen, C. S. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201111065 · Cited by 77
Epithelial Cell Cycle Behaviour in the Injured Kidney
Moonen, L., D’Haese, P. C., & Vervaet, B. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072038 · Cited by 72
Multistage Vectored siRNA Targeting Ataxia‐Telangiectasia Mutated for Breast Cancer Therapy
Xu, R., Huang, Y., Mai, J., Zhang, G., Guo, X., Xia, X., Koay, E. J., Qin, G., Erm, D. R., Li, Q., et al. (2013) · Small · doi:10.1002/smll.201201510 · Cited by 71
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells
Lim, Y. C., Roberts, T. L., Day, B. W., Stringer, B. W., Kozlov, S., Fazry, S., Bruce, Z. C., Ensbey, K. S., Walker, D., Boyd, A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.012 · Cited by 69
Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy
Willoughby, C. E., Jiang, Y., Thomas, H. D., Willmore, E., Kyle, S., Wittner, A., Phillips, N., Zhao, Y., Tudhope, S. J., Prendergast, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127483 · Cited by 72
Self-citation
Human Papillomavirus Episome Stability Is Reduced by Aphidicolin and Controlled by DNA Damage Response Pathways
Edwards, T. G., Helmus, M. J., Koeller, K. J., Bashkin, J. K., & Fisher, C. (2013) · Journal of Virology · doi:10.1128/jvi.03473-12 · Cited by 71
Phosphorylation of polynucleotide kinase/ phosphatase by DNA-dependent protein kinase and ataxia-telangiectasia mutated regulates its association with sites of DNA damage
Zolner, A. E., Abdou, I., Ye, R., Mani, R. S., Fanta, M., Yu, Y., Douglas, P., Tahbaz, N., Fang, S., Dobbs, T. A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr647 · Cited by 71
Serine 15 Phosphorylation of p53 Directs Its Interaction with B56γ and the Tumor Suppressor Activity of B56γ-Specific Protein Phosphatase 2A
Shouse, G., Cai, X., & Liu, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-07 · Cited by 72
Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium
Moding, E. J., Lee, C., Castle, K. D., Oh, P., Mao, L., Zha, S., Min, H. D., Ma, Y., Das, S. K., & Kirsch, D. G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73932 · Cited by 73
Parallel pathways in RAF-induced senescence and conditions for its reversion
Jeanblanc, M., Ragu, S., Gey, C., Contrepois, K., Courbeyrette, R., Thuret, J., & Mann, C. (2011) · Oncogene · doi:10.1038/onc.2011.481 · Cited by 74
Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein
Kulkarni, A., Oza, J. H., Yao, M., Sohail, H., Ginjala, V., Tomás‐Loba, A., Hořejšı́, Z., Tan, A. R., Boulton, S. J., & Ganesan, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.459164 · Cited by 71
ATM-mediated KDM2A phosphorylation is required for the DNA damage repair
Cao, L.-L., Wei, F., Du, Y., Song, B., Wang, D., Shen, C., Lu, X., Cao, Z., Yang, Q., Gao, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.81 · Cited by 72
Self-citation
Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency
Schneider, L. X., Fumagalli, M., & di Fagagna, F. D. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.129 · Cited by 72
ATR kinase activation in G1 phase facilitates the repair of ionizing radiation-induced DNA damage
Gamper, A. M., Rofougaran, R., Watkins, S. C., Greenberger, J. S., Beumer, J. H., & Bakkenist, C. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt833 · Cited by 71
E3 Ubiquitin Ligases RNF20 and RNF40 Are Required for Double-Stranded Break (DSB) Repair: Evidence for Monoubiquitination of Histone H2B Lysine 120 as a Novel Axis of DSB Signaling and Repair
So, C. C., Ramachandran, S., & Martín, A. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00488-18 · Cited by 73
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease
Tidball, A. M., Bryan, M. R., Uhouse, M. A., Kumar, K. K., Aboud, A. A., Feist, J. E., Ess, K. C., Neely, M. D., Aschner, M., & Bowman, A. B. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu609 · Cited by 68
Molecular basis of human ATM kinase inhibition
Stakyte, K., Rotheneder, M., Lammens, K., Bartho, J. D., Grädler, U., Fuchß, T., Pehl, U., Alt, A., van de Logt, E., & Hopfner, K. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00654-x · Cited by 66
APRIN is a cell cycle specific BRCA2‐interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer
Brough, R., Bajrami, I., Vatcheva, R., Natrajan, R., Reis-Filho, J. S., Lord, C. J., & Ashworth, A. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.490 · Cited by 69
Sp1 Facilitates DNA Double-Strand Break Repair through a Nontranscriptional Mechanism
Beishline, K., Kelly, C. M., Olofsson, B. A., Koduri, S., Emrich, J., Greenberg, R. A., & Azizkhan‐Clifford, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-12 · Cited by 70
Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling
Yamauchi, M., Oka, Y., Yamamoto, M., Niimura, K., Uchida, M., Kodama, S., Watanabe, M., Sekine, I., Yamashita, S., & Suzuki, K. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.11.011 · Cited by 70
ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells
Nadkarni, A., Shrivastav, M., Mladek, A. C., Schwingler, P. M., Grogan, P. T., Chen, J., & Sarkaria, J. N. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0979-0 · Cited by 70
New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors
Srougi, M. C., Bey, E. A., Dong, Y., Reinicke, K. E., & Boothman, D. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9043-8 · Cited by 68
The Mre11-Rad50-Nbs1 (MRN) complex has a specific role in the activation of Chk1 in response to stalled replication forks
Lee, J., & Dunphy, W. G. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-01-0025 · Cited by 71
Non-homologous end joining in class switch recombination: the beginning of the end
Kotnis, A. L., Du, L., Liu, C., Popov, S., & Pan‐Hammarström, Q. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0196 · Cited by 74
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer
Randon, G., Fucà, G., Rossini, D., Raimondi, A., Pagani, F., Perrone, F., Tamborini, E., Busico, A., Peverelli, G., Morano, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39525-3 · Cited by 68
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53
Sullivan, K. D., Padilla-Just, N., Henry, R. E., Porter, C. C., Kim, J., Tentler, J. J., Eckhardt, S. G., Tan, A. C., DeGregori, J., & Espinosa, J. M. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.965 · Cited by 67
Dppa2/4 Facilitate Epigenetic Remodeling during Reprogramming to Pluripotency
Hernandez, C. C., Wang, Z., Ramazanov, B. R., Tang, Y., Mehta, S. S., Dambrot, C., Lee, Y.-W., Tessema, K. K., Kumar, I., Astudillo, M. G., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.08.001 · Cited by 65
Pulsatile MAPK Signaling Modulates p53 Activity to Control Cell Fate Decisions at the G2 Checkpoint for DNA Damage
De, S., Campbell, C., Venkitaraman, A. R., & Esposito, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.074 · Cited by 67
Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells
Ivanov, V. N., Zhou, H., Partridge, M. A., & Hei, T. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3883 · Cited by 67
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
Palmieri, D., Valentino, T., D’Angelo, D., Martino, I. D., Postiglione, I., Pacelli, R., Croce, C. M., Fedele, M., & Fusco, A. (2011) · Oncogene · doi:10.1038/onc.2011.21 · Cited by 68
Personalized therapies in the cancer "omics" era
Ocaña, A., & Pandiella, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-202 · Cited by 68
Identification and Biological Evaluation of a Novel and Potent Small Molecule Radiation Sensitizer via an Unbiased Screen of a Chemical Library
Lally, B. E., Geiger, G. A., Kridel, S. J., Arcury‐Quandt, A. E., Robbins, M. E. C., Kock, N. D., Wheeler, K. T., Peddi, P., Georgakilas, A. G., Kao, G. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0477 · Cited by 68
Breaking the DNA damage response to improve cervical cancer treatment
Wieringa, H. W., van der Zee, A. G. J., de Vries, E. G. E., & van Vugt, M. A. T. M. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.008 · Cited by 66
Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice
Karlin, J. D., Allen, J., Ahmad, S. F., Hughes, G. D., Sheridan, V. H., Odedra, R., Farrington, P. M., Cadogan, E. B., Riches, L. C., Garcia-Trinidad, A., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0975 · Cited by 70
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
Jividen, K., Kedzierska, K., Yang, C., Szlachta, K. A., Ratan, A., & Paschal, B. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4848-x · Cited by 68
Transient ATM Kinase Inhibition Disrupts DNA Damage–Induced Sister Chromatid Exchange
White, J. S., Choi, S., & Bakkenist, C. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000758 · Cited by 66
N6-Furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylation
Bowie, L. E., Maiuri, T., Alpaugh, M., Gabriel, M. A., Arbez, N., Galleguillos, D., Hung, C. L.-K., Patel, S., Xia, J., Hertz, N. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801772115 · Cited by 65
F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress
Malonia, S. K., Dutta, P., Santra, M. K., & Green, M. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510929112 · Cited by 66
Bocavirus Infection Induces a DNA Damage Response That Facilitates Viral DNA Replication and Mediates Cell Death
Luo, Y., Chen, A. Y., & Qiu, J. (2010) · Journal of Virology · doi:10.1128/jvi.01534-10 · Cited by 66
Molecular Regulation of DNA Damage-Induced Apoptosis in Neurons of Cerebral Cortex
Martin, L. J., Liu, Z., Pipino, J., Chestnut, B., & Landek‐Salgado, M. A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn167 · Cited by 67
Small molecule–based reversible reprogramming of cellular lifespan
Won, J., Kim, M. K., Kim, N., Ahn, J. H., Lee, W. G., Kim, S. S., Chang, K.-Y., Yi, Y.-W., & Kim, T. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio800 · Cited by 68
Retracted
DNA Damage Responses at Low Radiation Doses
Short, S. C., Bourne, S., Martindale, C. A., Woodcock, M., & Jackson, S. P. (2005) · Radiation Research · doi:10.1667/rr3421.1 · Cited by 66
Self-citation
Targeting the DNA damage response in oncology
Basu, B., Yap, T. A., Molife, L. R., & Bono, J. S. D. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835280c6 · Cited by 68
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
Wang, Y., Liu, Q., Liu, Z., Li, B., Sun, Z.-L., Zhou, H., Zhang, X., Gong, Y., & Shao, C. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.04.005 · Cited by 66
DNA damage responses in cells exposed to sulphur mustard
Jowsey, P. A., Williams, F. M., & Blain, P. G. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.11.009 · Cited by 67
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
Tavecchio, M., Munck, J. M., Cano, C., Newell, D. R., & Curtin, N. J. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1662-4 · Cited by 63
Self-citation
Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress
Furusawa, Y., Iizumi, T., Fujiwara, Y., Zhao, Q., Tabuchi, Y., Nomura, T., & Kondo, T. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0660-7 · Cited by 65
E3 Ubiquitin Ligase HOIP Attenuates Apoptotic Cell Death Induced by Cisplatin
MacKay, C., Carroll, E., Ibrahim, A. F. M., Garg, A. K., Inman, G. J., Hay, R. T., & Alpi, A. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2131 · Cited by 65
DNA repair mechanisms protect our genome from carcinogenesis
Moraes, M. C. S. (2012) · Frontiers in Bioscience · doi:10.2741/3992 · Cited by 64
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair
Konstantinopoulos, P. A., Lheureux, S., & Moore, K. N. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_288015 · Cited by 65

Authors: Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M.
Affiliations: 1KuDOS Pharmaceuticals Ltd., Cambridge Science Park, Milton Road, Cambridge;
Newcastle University (GB)
University of Cambridge (GB)
ORCID: Hickson, Ian
Zhao, Yan
Martin, Niall M. B.
Jackson, Stephen P.
Curtin, Nicola J.
Smith, Graeme C. M.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-12-15
Volume: 64
Issue: 24
Pages: 9152-9159
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-04-2727
OpenAlex: W2101988823
Cited by: 1,220
References: 58
Citations by year: 2026: 26 · 2025: 31 · 2024: 38 · 2023: 49 · 2022: 31 · 2021: 32 · 2020: 53 · 2019: 55 · 2018: 48 · 2017: 66 · 2016: 71 · 2015: 76 · 2014: 70 · 2013: 62 · 2012: 92
FWCI: 11.39
Type: journal article
Language: en
Open access: green
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords: ATM kinase, KU55933, kinase inhibitors, ataxia telangiectasia, radiosensitivity, DNA double-strand breaks, cell cycle arrest, p53 phosphorylation, NBS1, radiosensitization, chemosensitization, etoposide, doxorubicin, camptothecin, γH2AX, SMC1A
MeSH terms: Cell Cycle, Chromones, DNA-Binding Proteins, HeLa Cells, Humans, Kinetics, Morpholines, Phosphorylation, Pyrones, Radiation-Sensitizing Agents, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Inhibitory Concentration 50, Combinatorial Chemistry Techniques, Tumor Suppressor Proteins, Cell Line, Tumor, Protein Kinase Inhibitors, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks